Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

ProSciento Inc.

Neither a doctor nor a teaching hospital

Research payments

$2,773,865

44 payments

Through program year 2025, ProSciento Inc. is reported as receiving $2,773,865 in research payments, across 44 payments.

By program year

6 rows
Year Kind Amount Payments
2025 Research $1,053,231 2
2024 Research $93,665 5
2023 Research $213,782 7
2021 Research $165,153 4
2020 Research $216,057 8
2019 Research $1,031,975 18

Breakdown

Who paid Research payments · program years 2019–2025
  1. Merck Sharp & Dohme Corporation $2,505,556 34 payments
  2. Xeris Pharmaceuticals, Inc. $268,308 10 payments
Studies the money was for Research payments · program years 2019–2025
  1. A multiple-dose clinical study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of MK-3655 in overweight,obese participants with elevated liver fat. $1,209,295 20 payments
  2. A Noninterventional Study to Evaluate Inflammatory Biomarkers in Different Patient Populations Compared to Healthy Participants. $903,367 1 payment
  3. Xp-8121-120 $268,308 10 payments
  4. A Noninterventional Study to Evaluate Inflammatory Biomarkers in Different Patient Populations Compared to Healthy Participants. $149,865 1 payment
  5. A Single Ascending Dose Clinical Trial to Study the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1092 in Healthy Subjects, Subjects with Type 1 Diabetes Mellitus, and Subjects with Type 2 Diabetes Mellitus $103,337 5 payments
  6. A 2-part, open-label, single-dose study to investigate the influence of hepatic impairment on the pharmacokinetics of MK-8189 $100,009 3 payments
  7. A Noninterventional Study to Evaluate Inflammatory Biomarkers in Different Patient Populations Compared to Healthy Participants. $39,139 2 payments
  8. A multiple-dose clinical study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of MK-3655 in overweight,obese participants with elevated liver fat. $546 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record